Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Oosterwijk

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2012
Clinicopathologic characteristics and survival in BRCA1- and BRCA2-related adnexal cancer: are they different?Welmoed Reitsma, Geertruida H de Bock, Jan C Oosterwijk, et al.
Breast Cancer Research and Treatment|March 5, 2011
Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomyIngrid E Fakkert, Liesbeth Jansen, Kees Meijer, et al.
BMC Cancer|October 7, 2008
Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counsellingCaroline F Ockhuysen-Vermey, Lidewij Henneman, Christi J van Asperen, et al.
Psycho-Oncology|June 29, 2012
The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology mattersJoël Vos, Christi J van Asperen, Jan C Oosterwijk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2017
The BRCA1/2 Parent-of-Origin Effect on Breast Cancer Risk-ResponseJanet R Vos, Jan C Oosterwijk, Matti A Rookus, et al.
American Journal of Medical Genetics. Part A|August 19, 2004
Inheritance of most X-linked traits is not dominant or recessive, just X-linkedWilliam B Dobyns, Allison Filauro, Brett N Tomson, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 3, 2015
[CHEK2-mutation in Dutch breast cancer families: expanding genetic testing for breast cancer]Muriel A Adank, Frederik J Hes, Wendy A G van Zelst-Stams, et al.
European Radiology|June 29, 2010
Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysisMarijke C Jansen-van der Weide, Marcel J W Greuter, Liesbeth Jansen, et al.
Maturitas|November 26, 2013
Risk-reducing mastectomy in BRCA1/2 mutation carriers: factors influencing uptake and timingCatheleine M van Driel, Yassir Eltahir, Jakob de Vries, et al.
Breast (Edinburgh, Scotland)|March 25, 2019
Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysisXuan-Anh Phi, Marcel J W Greuter, Inge-Marie Obdeijn, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2012
Clinicopathologic characteristics and survival in BRCA1- and BRCA2-related adnexal cancer: are they different?Welmoed Reitsma, Geertruida H de Bock, Jan C Oosterwijk, et al.
Breast Cancer Research and Treatment|March 5, 2011
Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomyIngrid E Fakkert, Liesbeth Jansen, Kees Meijer, et al.
BMC Cancer|October 7, 2008
Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counsellingCaroline F Ockhuysen-Vermey, Lidewij Henneman, Christi J van Asperen, et al.
Psycho-Oncology|June 29, 2012
The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology mattersJoël Vos, Christi J van Asperen, Jan C Oosterwijk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2017
The BRCA1/2 Parent-of-Origin Effect on Breast Cancer Risk-ResponseJanet R Vos, Jan C Oosterwijk, Matti A Rookus, et al.
American Journal of Medical Genetics. Part A|August 19, 2004
Inheritance of most X-linked traits is not dominant or recessive, just X-linkedWilliam B Dobyns, Allison Filauro, Brett N Tomson, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 3, 2015
[CHEK2-mutation in Dutch breast cancer families: expanding genetic testing for breast cancer]Muriel A Adank, Frederik J Hes, Wendy A G van Zelst-Stams, et al.
European Radiology|June 29, 2010
Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysisMarijke C Jansen-van der Weide, Marcel J W Greuter, Liesbeth Jansen, et al.
Maturitas|November 26, 2013
Risk-reducing mastectomy in BRCA1/2 mutation carriers: factors influencing uptake and timingCatheleine M van Driel, Yassir Eltahir, Jakob de Vries, et al.
Breast (Edinburgh, Scotland)|March 25, 2019
Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysisXuan-Anh Phi, Marcel J W Greuter, Inge-Marie Obdeijn, et al.
Pageof 10